Abstract

In current work the interaction of doxorubicine-containing lipophilic nanocarriers and human breast cancer MCF-7 cells was revealed. The mechanism, dynamics and efficiency of nanoparticle’s penetration was studied.

© 2012 OSA

PDF Article